Gout Drug Shows Promise for Myocardial Injury in Covid-19 Patients
Colchicine-treated patients had longer time to clinical deterioration in GRECCO-19 study Patients...
Read More
FDA / Research
Covid-19: Is There An ’Immunity Shield’ Post-Infection?
An observational study says ’no,’ suggests neutralizing antibodies in SARS-CoV-2 rapidly fade away...
Read More
As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.
Read More
Blood Type May Play a Role in Covid-19 Severity
Type O blood linked to lower respiratory failure in study Genetic analysis involving Covid-19...
Read More
Covid-19: Study Finds Convalescent Plasma Safe
Signal promising but efficacy needs to be confirmed Covid-19 convalescent plasma appears safe for...
Read More
Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis.
To assess the overall prevalence of clinical signs, symptoms, and radiological findings in...
Read More
Covid-19: FDA Warns Companies Selling Antibody Tests
Agency cites 3 companies for selling unapproved direct-to-consumer tests WASHINGTON — Three...
Read More
Citing COVID, Sutter Pushes To Revisit Landmark Antitrust Settlement
Six months after agreeing to a $575 million settlement in a landmark antitrust case, Sutter Health has yet to pay a single dollar and now says the terms may be untenable, given the strain caused by the pandemic.
Read More
Covid-19: 1 in 5 People Worldwide at Risk for Severe Illness
Modeling assessed risk based on comorbid conditions such as CVD, diabetes, HIV/AIDS, certain...
Read More
Strong Support Found for Protective Practices Related to COVID-19
WEDNESDAY, June 17, 2020 (HealthDay News) — Most adults in New York City, Los Angeles, and...
Read More
Risk for COVID-19 Reinfection Remains Unknown
WEDNESDAY, June 17, 2020 (HealthDay News) — The potential risk for reinfection with COVID-19...
Read More
Covid-19: FDA Warns of Drug-Drug Interaction if Remdesivir Given with HCQ, Chloroquine
Agency strikes another blow for malaria agents’s use against Covid-19 WASHINGTON —...
Read More
Covid-19: Dexamethasone May Help Severely Ill Patients
Preliminary RECOVERY study results show mortality reduction for those requiring respiratory...
Read More
Hotter Temperatures, Higher Humidity May Reduce Covid-19 Spread
Climate may play key role in SARS-CoV-2 transmission New research adds to the early evidence that...
Read More
Covid-19: FDA Revokes Emergency Authorization for Hydroxychloroquine, Chloroquine
Agency says criteria for EUA no longer met WASHINGTON — Based on a review of information emerging...
Read More
Phase 3 of Moderna’s Vaccine Starts July 2020 with 30,000 People
Phase 3 study of 30,000 subjects expected to begin in July 2020 at 100 μg dose level Moderna, a...
Read More
COVID-19 Behavior Seems Consistent With Seasonal Virus
THURSDAY, June 11, 2020 (HealthDay News) — Eight cities with substantial community outbreaks...
Read More
Acalabrutinib Promising for Treatment of Severe COVID-19
THURSDAY, June 11, 2020 (HealthDay News) — For patients with severe COVID-19, treatment with...
Read More
Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.
In the absence of a vaccine or specific drug treatment options for coronavirus disease (COVID-19),...
Read More